Country
Pfizer's Ibrance drug slows progression of breast cancer
A Phase III trial of Pfizer Inc's Ibrance showed that, in combination with hormone therapy, the drug more than doubled the duration of disease control for women with the most common type of breast cancer.
Stifel in lead to buy Barclays' U.S. wealth unit - sources
Investment bank Stifel Financial Corp (SF.N) is in advanced negotiations to acquire Barclays Plc's (BARC.L) U.S wealth management unit, according to three people familiar with the situation.
Greece open to compromise to seal deal this week: interior minister
Greece's government is confident of reaching a deal with its creditors this week and is open to pushing back parts of its anti-austerity program to make that happen, the country's interior minister said Saturday.
Micromanaging new CEO impresses at Malaysia Airlines but doubts run deep
New CEO Christoph Mueller's plans for troubled Malaysia Airlines - including a new brand, a smaller fleet and one third less staff - are widely seen as a promising blueprint for a fresh start.